Table 3.
Comparison of Various Characteristics N (%), Median [IQR]. (A) A Comparison of the Clinical Characteristics between Ambulance Admission and Walk-in Groups. (B) A Comparison of the Clinical Characteristics Depending on the Number of Bite Marks. (C) A Comparison of the Clinical Characteristics between the Groups with and without Tourniquet Use during Hospitalization.
| A. | ||||
| Variable | walk-in [n=66] | ambulance [n=30] | Statistic (Wilcoxon rank-sum test) |
p value |
|---|---|---|---|---|
| Number | ||||
| Sex (Female) | 25 (37.9) | 10 (33.3) | - | 0.820 |
| More than Grade III | 33 (51.6) | 6 (20.7) | - | 0.006 |
| (on admission) | ||||
| Exacerbation | 20 (31.3) | 11 (37.9) | - | 0.636 |
| (in hospital) | ||||
| Creatinine kinase (U/L) | 135 [92-207] | 157 [115-208] | 1,590.5 | 0.230 |
| (on admission) | ||||
| Hospitalization | 6.0 [4.0-8.0] | 5.5 [3.0-7.0] | 1,371.0 | 0.504 |
| B. | ||||
| Variable | One [n=22] | two [n=56] | Statistic (Wilcoxon rank-sum test) |
p value |
| Number | - | - | ||
| Sex (Female) | 9 (40.99 | 25 (44.6) | - | 0.805 |
| More than Grade III | 8 (36.4) | 23 (42.6) | - | 0.798 |
| (on admission) | ||||
| Exacerbation | 6 (27.3) | 19 (35.2) | - | 0.597 |
| (in hospital) | ||||
| Creatinine kinase (U/L) | 141.5 [92.0-164.0] | 133.0 [105.0-209.0] | 811.0 | 0.600 |
| (on admission) | ||||
| Hospitalization | 6.0 [4.0-7.0] | 6.5 [3.0-8.0] | 820.0 | 0.587 |
| C. | ||||
| Variable | tourniquet [n=62] | non-tourniquet [n=51] | Statistic (Wilcoxon rank-sum test) |
p value |
| Number | - | - | ||
| Sex (Female) | 20 (32.3) | 22 (43.1) | - | 0.248 |
| Exacerbation | 29 (49.2) | 10 (19.6) | - | 0.001 |
| (in hospital) | ||||
| Hospitalization | 6.0 [3.0-8.0] | 6.0 [4.0-8.0] | 2,959.0 | 0.765 |
CPK: Creatine Phosphokinase